Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities

Roberto Chiesa, Pedro Piccardo, Emiliano Biasini, Bernardino Ghetti, David A. Harris

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The neurotoxic forms of the prion protein (PrP) that cause neurodegeneration in prion diseases remain to be conclusively identified. Considerable evidence points to the importance of noninfectious oligomers of PrP in the pathogenic process. In this study, we describe lines of Tg(WT) transgenic mice that over-express wild-type PrP by either ∼5-fold or ∼10-fold (depending on whether the transgene array is, respectively, hemizygous or homozygous). Homozygous but not hemizygous Tg(WT) mice develop a spontaneous neurodegenerative illness characterized clinically by tremor and paresis. Both kinds of mice accumulate large numbers of punctate PrP deposits in the molecular layer of the cerebellum as well as in several other brain regions, and they display abnormally enlarged synaptic terminals accompanied by a dramatic proliferation of membranous structures. The over-expressed PrP in Tg(WT) mice assembles into an insoluble form that is mildly protease-resistant and is recognizable by aggregation-specific antibodies, but that is not infectious in transmission experiments. Together, our results demonstrate that noninfectious aggregates of wild-type PrP are neurotoxic, particularly to synapses, and they suggest common pathogenic mechanisms shared by prion diseases and nontransmissible neurodegenerative disorders associated with protein misfolding.

Original languageEnglish
Pages (from-to)13258-13267
Number of pages10
JournalJournal of Neuroscience
Volume28
Issue number49
DOIs
StatePublished - Dec 3 2008

Fingerprint

Prion Diseases
Presynaptic Terminals
Tremor
Paresis
Transgenes
Neurodegenerative Diseases
Synapses
Cerebellum
Transgenic Mice
Prion Proteins
Peptide Hydrolases
Antibodies
Brain
Proteins

Keywords

  • Neurodegeneration
  • Prion
  • Protein aggregation
  • Synapse
  • Transgenic
  • Wild-type

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)

Cite this

Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities. / Chiesa, Roberto; Piccardo, Pedro; Biasini, Emiliano; Ghetti, Bernardino; Harris, David A.

In: Journal of Neuroscience, Vol. 28, No. 49, 03.12.2008, p. 13258-13267.

Research output: Contribution to journalArticle

Chiesa, Roberto ; Piccardo, Pedro ; Biasini, Emiliano ; Ghetti, Bernardino ; Harris, David A. / Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities. In: Journal of Neuroscience. 2008 ; Vol. 28, No. 49. pp. 13258-13267.
@article{0412a72406914318b1c7836fcf067dbc,
title = "Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities",
abstract = "The neurotoxic forms of the prion protein (PrP) that cause neurodegeneration in prion diseases remain to be conclusively identified. Considerable evidence points to the importance of noninfectious oligomers of PrP in the pathogenic process. In this study, we describe lines of Tg(WT) transgenic mice that over-express wild-type PrP by either ∼5-fold or ∼10-fold (depending on whether the transgene array is, respectively, hemizygous or homozygous). Homozygous but not hemizygous Tg(WT) mice develop a spontaneous neurodegenerative illness characterized clinically by tremor and paresis. Both kinds of mice accumulate large numbers of punctate PrP deposits in the molecular layer of the cerebellum as well as in several other brain regions, and they display abnormally enlarged synaptic terminals accompanied by a dramatic proliferation of membranous structures. The over-expressed PrP in Tg(WT) mice assembles into an insoluble form that is mildly protease-resistant and is recognizable by aggregation-specific antibodies, but that is not infectious in transmission experiments. Together, our results demonstrate that noninfectious aggregates of wild-type PrP are neurotoxic, particularly to synapses, and they suggest common pathogenic mechanisms shared by prion diseases and nontransmissible neurodegenerative disorders associated with protein misfolding.",
keywords = "Neurodegeneration, Prion, Protein aggregation, Synapse, Transgenic, Wild-type",
author = "Roberto Chiesa and Pedro Piccardo and Emiliano Biasini and Bernardino Ghetti and Harris, {David A.}",
year = "2008",
month = "12",
day = "3",
doi = "10.1523/JNEUROSCI.3109-08.2008",
language = "English",
volume = "28",
pages = "13258--13267",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "49",

}

TY - JOUR

T1 - Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities

AU - Chiesa, Roberto

AU - Piccardo, Pedro

AU - Biasini, Emiliano

AU - Ghetti, Bernardino

AU - Harris, David A.

PY - 2008/12/3

Y1 - 2008/12/3

N2 - The neurotoxic forms of the prion protein (PrP) that cause neurodegeneration in prion diseases remain to be conclusively identified. Considerable evidence points to the importance of noninfectious oligomers of PrP in the pathogenic process. In this study, we describe lines of Tg(WT) transgenic mice that over-express wild-type PrP by either ∼5-fold or ∼10-fold (depending on whether the transgene array is, respectively, hemizygous or homozygous). Homozygous but not hemizygous Tg(WT) mice develop a spontaneous neurodegenerative illness characterized clinically by tremor and paresis. Both kinds of mice accumulate large numbers of punctate PrP deposits in the molecular layer of the cerebellum as well as in several other brain regions, and they display abnormally enlarged synaptic terminals accompanied by a dramatic proliferation of membranous structures. The over-expressed PrP in Tg(WT) mice assembles into an insoluble form that is mildly protease-resistant and is recognizable by aggregation-specific antibodies, but that is not infectious in transmission experiments. Together, our results demonstrate that noninfectious aggregates of wild-type PrP are neurotoxic, particularly to synapses, and they suggest common pathogenic mechanisms shared by prion diseases and nontransmissible neurodegenerative disorders associated with protein misfolding.

AB - The neurotoxic forms of the prion protein (PrP) that cause neurodegeneration in prion diseases remain to be conclusively identified. Considerable evidence points to the importance of noninfectious oligomers of PrP in the pathogenic process. In this study, we describe lines of Tg(WT) transgenic mice that over-express wild-type PrP by either ∼5-fold or ∼10-fold (depending on whether the transgene array is, respectively, hemizygous or homozygous). Homozygous but not hemizygous Tg(WT) mice develop a spontaneous neurodegenerative illness characterized clinically by tremor and paresis. Both kinds of mice accumulate large numbers of punctate PrP deposits in the molecular layer of the cerebellum as well as in several other brain regions, and they display abnormally enlarged synaptic terminals accompanied by a dramatic proliferation of membranous structures. The over-expressed PrP in Tg(WT) mice assembles into an insoluble form that is mildly protease-resistant and is recognizable by aggregation-specific antibodies, but that is not infectious in transmission experiments. Together, our results demonstrate that noninfectious aggregates of wild-type PrP are neurotoxic, particularly to synapses, and they suggest common pathogenic mechanisms shared by prion diseases and nontransmissible neurodegenerative disorders associated with protein misfolding.

KW - Neurodegeneration

KW - Prion

KW - Protein aggregation

KW - Synapse

KW - Transgenic

KW - Wild-type

UR - http://www.scopus.com/inward/record.url?scp=58149399384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149399384&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3109-08.2008

DO - 10.1523/JNEUROSCI.3109-08.2008

M3 - Article

C2 - 19052217

AN - SCOPUS:58149399384

VL - 28

SP - 13258

EP - 13267

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 49

ER -